A newly developed and validated computational model of the undiseased human ventricular action potential provides a robust tool for investigating cardiac electrophysiology and genetic mutations such as Long-QT.
Answers are grounded in this paper and cite their sources.
Offers validated human ventricular model for mutation studies; leaves open clinical translation pending further validation.
Creation of an accurate model for the undiseased human ventricular action potential: AP) which reproduces a broad range of physiological behaviors requires extensive experimental data, of which essential elements have been unavailable. We developed and validated such a model using new experimental data from endocardium of 140 undiseased human hearts. 78 were from male: 56%). Average age was 41 with standard deviation of 12 years. New experiments include: Ca2+ versus voltage dependent inactivation of L-type Ca2+ current; kinetics for the transient outward, rapid delayed rectifier, Na+/Ca2+ exchange, and inward rectifier currents; AP recordings at all physiological cycle lengths; steady state rate dependence and restitution of AP duration. The model was used to investigate the "silent" Long-QT mutation Q357R in KCNQ1.
No takes yet. Share an insight, caveat, or question.
Tom O’Hara (2011) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: